CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and Apoptosis
Xiaoli Li(Affiliated Hospital of Hebei University), Weiying Zhou(Chongqing Medical University)
Cited by 34
Related Papers
Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells
|OncoTargets and Therapy|2018|40
Quercetin Suppresses Human Glioblastoma Migration and Invasion via GSK3β/β-catenin/ZEB1 Signaling Pathway
|Frontiers in Pharmacology|2022|33
Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway In Vivo and In Vitro
|Frontiers in Pharmacology|2022|15
<p>The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct</p>
|OncoTargets and Therapy|2020|12
Gas6/Axl signaling pathway promotes proliferation, migration and invasion and inhibits apoptosis in A549 cells
|Experimental and Therapeutic Medicine|2021|12